FI960253L - Aerosolisoitujen proteiinien stabilointi - Google Patents

Aerosolisoitujen proteiinien stabilointi Download PDF

Info

Publication number
FI960253L
FI960253L FI960253A FI960253A FI960253L FI 960253 L FI960253 L FI 960253L FI 960253 A FI960253 A FI 960253A FI 960253 A FI960253 A FI 960253A FI 960253 L FI960253 L FI 960253L
Authority
FI
Finland
Prior art keywords
stabilization
aerosolized
proteins
aerosolized proteins
Prior art date
Application number
FI960253A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI960253A7 (fi
FI960253A0 (fi
Inventor
Tsutomu Arakawa
Ralph W Niven
Steven J Prestrelski
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of FI960253A0 publication Critical patent/FI960253A0/fi
Publication of FI960253A7 publication Critical patent/FI960253A7/fi
Publication of FI960253L publication Critical patent/FI960253L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Colloid Chemistry (AREA)
FI960253A 1993-07-19 1994-07-19 Aerosolisoitujen proteiinien stabilointi FI960253L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9384093A 1993-07-19 1993-07-19
PCT/US1994/008136 WO1995003034A1 (en) 1993-07-19 1994-07-19 Stabilization of aerosolized proteins

Publications (3)

Publication Number Publication Date
FI960253A0 FI960253A0 (fi) 1996-01-18
FI960253A7 FI960253A7 (fi) 1996-03-18
FI960253L true FI960253L (fi) 1996-03-18

Family

ID=22241106

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960253A FI960253L (fi) 1993-07-19 1994-07-19 Aerosolisoitujen proteiinien stabilointi

Country Status (8)

Country Link
EP (1) EP0710102A1 (de)
JP (1) JPH09501418A (de)
AU (1) AU691514B2 (de)
CA (1) CA2167538A1 (de)
FI (1) FI960253L (de)
NO (1) NO960217L (de)
NZ (1) NZ271181A (de)
WO (1) WO1995003034A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
DE19733651A1 (de) * 1997-08-04 1999-02-18 Boehringer Ingelheim Pharma Wässrige Aerosolzubereitungen enthaltend biologisch aktive Markomoleküle und Verfahren zur Erzeugung entsprechender Aerosole
EP1244432A2 (de) * 1999-12-30 2002-10-02 Chiron Corporation Verfahren zur pulmonaren verabreichung von interleukin-2
DK1129720T3 (da) 2000-02-29 2004-09-27 Pfizer Prod Inc Stabiliseret granulocyt-kolonistimulerende faktor
EP1471871B1 (de) 2001-02-02 2007-05-02 Ortho-McNeil Pharmaceutical, Inc. Behandlung von neurologischen funktionsstörungen mit fructopyranosesulfamaten und erythropoetin
US20030072717A1 (en) 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
WO2002094342A2 (en) * 2001-05-21 2002-11-28 Vapotronics, Inc. Compositions for protein delivery via the pulmonary route
JP2004087560A (ja) 2002-08-23 2004-03-18 Sansha Electric Mfg Co Ltd 電源装置
TW200938222A (en) * 2007-12-13 2009-09-16 Glaxo Group Ltd Compositions for pulmonary delivery
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
JP5763053B2 (ja) 2009-05-18 2015-08-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング アダプタ、吸入器具及びアトマイザ
PE20130036A1 (es) 2009-11-25 2013-02-03 Boehringer Ingelheim Int Nebulizador
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
CN103717239B (zh) 2011-08-02 2017-08-01 希格马托制药工业公司 适合于吸入的氧化抗生物素蛋白的药物组合物
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
EP3030298B1 (de) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Vernebler
EP2835146B1 (de) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Zerstäuber
AP2016009486A0 (en) 2014-05-07 2016-10-31 Boehringer Ingelheim Int Nebulizer, indicator device and container
HUE055604T2 (hu) 2014-05-07 2021-12-28 Boehringer Ingelheim Int Porlasztó
WO2015169732A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, nebulizer and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897256A (en) * 1986-11-25 1990-01-30 Abbott Laboratories LHRH analog formulations
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций

Also Published As

Publication number Publication date
NZ271181A (en) 1998-06-26
JPH09501418A (ja) 1997-02-10
NO960217D0 (no) 1996-01-18
AU7473294A (en) 1995-02-20
FI960253A7 (fi) 1996-03-18
FI960253A0 (fi) 1996-01-18
NO960217L (no) 1996-03-18
EP0710102A1 (de) 1996-05-08
AU691514B2 (en) 1998-05-21
CA2167538A1 (en) 1995-02-02
WO1995003034A1 (en) 1995-02-02

Similar Documents

Publication Publication Date Title
FI960253L (fi) Aerosolisoitujen proteiinien stabilointi
DE69422575D1 (de) System zur Erklärung von Austellungsstücken
DE59405373D1 (de) Mehrfachnutzung von Blasluft
PT1066828E (pt) Composicao de aerossol
DE69418220D1 (de) Befestigung von Biomolekülen
DE69434520D1 (de) Biotinylierung von proteinen
DK91192D0 (da) Protein
BR9403948A (pt) Composição de matéria
BR9403946A (pt) Composição de matéria
FI954541L (fi) Keratinosyyttikasvutekijän terapeuttisia käyttöjä
FI952574L (fi) Glykosyylitransferaasiaktiiviset proteiinit
DE69304334D1 (de) L-klasse schmelzsicherung
DK132892D0 (da) Proteiner
KR960016892A (ko) 약제의 신독성 경감제
DE69426333D1 (de) Verbesserungen von antibakterischen zusammensetzungen
DE69417915D1 (de) Reinigung von uranhexafluorid
DK75393D0 (da) Production of protein
NO931399D0 (no) Anvendelse av naturstein
KR950003500U (ko) 냉동차의 분리형 냉동기
DE69404145D1 (de) Zusammensetzungen von stoffen
EP0562624A3 (en) Stabilization of functional proteins
NO952904D0 (no) Lysinsalt av 6-klor-5-fluor-3-(2-tenoyl)-2-oxindol-1-karboksamide
FI924835L (fi) Pectinatus-bakteerin proteiinifragmentteja
KR930026760U (ko) Tvcr의 개선된 구성
DE69325271D1 (de) Hydrosilylierung von fullarenen